Citeline’s Annual Clinical Trials Roundup 2025 Edition delivers a detailed analysis of 10,503 Phase I–III clinical trials initiated in 2024, revealing a 5.5% increase in trial starts and a 3.6% rise in industry-sponsored studies. After the rebound of 2023, this steady growth signals continued recovery across the global R&D landscape.
Inside, experts highlight where trial activity is accelerating, which therapeutic areas are driving innovation, and how regulatory and design trends are shaping the next wave of research.
If you’re planning or benchmarking trials in 2025, this report provides the data and context you need to make confident decisions.
Choose a time to talk
専門家との相談日時を選択
Calendar requires cookies. Enable cookies
カレンダーの表示にはCookieの有効化が必要です Cookieを有効にする
Or send us a message and we'll be in touch
面談の有無がお決まりでない場合は、お問い合わせ内容をお送りください。担当者よりご連絡いたします。